An interventional study of Visits conducted via Telemedicine in Cancer, Treatment-Related, sponsored by Grand River Hospital. Status unknown at 1 site in Canada. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-02-15.
Sponsored by Grand River Hospital · Not applicable, Interventional, and Other
This randomized, open label study will evaluate a nurse and pharmacist led clinic conducted remotely from Grand River Regional Cancer Centre at Grand River Hospital (GRRCC/GRH) using OTN teleconferencing as a platform for patients with prostate cancer receiving oral chemotherapy agents.
96 studies on the registry are indexed under Neoplasms, Second Primary; 35 are open to participants now.
This study's planned enrollment of 80 is close to the median of 82 across 48 interventional studies indexed under Neoplasms, Second Primary.
Browse Neoplasms, Second Primary studies →Grand River Hospital is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients lacking the technology at home to participate in the virtual telemedicine clinic. (excluding control group)
-
Pharmacist and nurse led OTN based remote teleconference based clinic (OTN) The OTN clinic will be conducted by providing the patient with a link via email which will allow the patient to access OTN teleconferencing and meet virtually with a pharmacist and nurse during a previously scheduled appointment. Virtual clinic appointments will be 30 minutes long and will consist of a patient assessment and open ended questions about the patient health status using a modified version of the validated MOATT (MASCC Oral Agent Teaching Tool) created by the Multidisciplinary Association of Supportive Care in Cancer.
Other: Visits conducted via Telemedicine
Patients are followed in person at the cancer clinic based on standard of care guidelines
Patients will be followed via telemedicine with visits lead by a Pharmacist and a Nurse
Patient satisfaction with overall care
The primary outcome will be a comparison of patient satisfaction with overall care utilizing a validated scale between the group of patients using the OTN clinic and a group of control patients receiving conventional care at GRRCC
Time frame: 2 Years
Plan to share: No
No publications or documents are linked to this record.
Started Oct 2016 (actual). Primary completion is estimated for Oct 2020, 48 months after the start.
Of 26 interventional studies with no phase under Neoplasms, Second Primary, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 61. This study's planned 48 months is above that.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.